186 related articles for article (PubMed ID: 37548038)
1. Severity of GNAO1-Related Disorder Correlates with Changes in G-Protein Function.
Domínguez-Carral J; Ludlam WG; Junyent Segarra M; Fornaguera Marti M; Balsells S; Muchart J; Čokolić Petrović D; Espinoza I; Ortigoza-Escobar JD; Martemyanov KA;
Ann Neurol; 2023 Nov; 94(5):987-1004. PubMed ID: 37548038
[TBL] [Abstract][Full Text] [Related]
2. Recurrent GNAO1 Mutations Associated With Developmental Delay and a Movement Disorder.
Menke LA; Engelen M; Alders M; Odekerken VJ; Baas F; Cobben JM
J Child Neurol; 2016 Dec; 31(14):1598-1601. PubMed ID: 27625011
[TBL] [Abstract][Full Text] [Related]
3. Spectrum of neurodevelopmental disease associated with the GNAO1 guanosine triphosphate-binding region.
Kelly M; Park M; Mihalek I; Rochtus A; Gramm M; Pérez-Palma E; Axeen ET; Hung CY; Olson H; Swanson L; Anselm I; Briere LC; High FA; Sweetser DA; ; Kayani S; Snyder M; Calvert S; Scheffer IE; Yang E; Waugh JL; Lal D; Bodamer O; Poduri A
Epilepsia; 2019 Mar; 60(3):406-418. PubMed ID: 30682224
[TBL] [Abstract][Full Text] [Related]
4. A mechanistic review on GNAO1-associated movement disorder.
Feng H; Khalil S; Neubig RR; Sidiropoulos C
Neurobiol Dis; 2018 Aug; 116():131-141. PubMed ID: 29758257
[TBL] [Abstract][Full Text] [Related]
5. Results of the First GNAO1-Related Neurodevelopmental Disorders Caregiver Survey.
Axeen E; Bell E; Robichaux Viehoever A; Schreiber JM; Sidiropoulos C; Goodkin HP
Pediatr Neurol; 2021 Aug; 121():28-32. PubMed ID: 34139551
[TBL] [Abstract][Full Text] [Related]
6. Mouse models of GNAO1-associated movement disorder: Allele- and sex-specific differences in phenotypes.
Feng H; Larrivee CL; Demireva EY; Xie H; Leipprandt JR; Neubig RR
PLoS One; 2019; 14(1):e0211066. PubMed ID: 30682176
[TBL] [Abstract][Full Text] [Related]
7. Movement disorder in
Feng H; Sjögren B; Karaj B; Shaw V; Gezer A; Neubig RR
Neurology; 2017 Aug; 89(8):762-770. PubMed ID: 28747448
[TBL] [Abstract][Full Text] [Related]
8. Genotype-phenotype correlation and treatment effects in young patients with
Thiel M; Bamborschke D; Janzarik WG; Assmann B; Zittel S; Patzer S; Auhuber A; Opp J; Matzker E; Bevot A; Seeger J; van Baalen A; Stüve B; Brockmann K; Cirak S; Koy A
J Neurol Neurosurg Psychiatry; 2023 Oct; 94(10):806-815. PubMed ID: 37225406
[TBL] [Abstract][Full Text] [Related]
9. Mice with
Larrivee CL; Feng H; Quinn JA; Shaw VS; Leipprandt JR; Demireva EY; Xie H; Neubig RR
J Pharmacol Exp Ther; 2020 Apr; 373(1):24-33. PubMed ID: 31907305
[TBL] [Abstract][Full Text] [Related]
10. Phenomenology and clinical course of movement disorder in GNAO1 variants: Results from an analytical review.
Schirinzi T; Garone G; Travaglini L; Vasco G; Galosi S; Rios L; Castiglioni C; Barassi C; Battaglia D; Gambardella ML; Cantonetti L; Graziola F; Marras CE; Castelli E; Bertini E; Capuano A; Leuzzi V
Parkinsonism Relat Disord; 2019 Apr; 61():19-25. PubMed ID: 30642806
[TBL] [Abstract][Full Text] [Related]
11. Caenorhabditis elegans provides an efficient drug screening platform for GNAO1-related disorders and highlights the potential role of caffeine in controlling dyskinesia.
Di Rocco M; Galosi S; Lanza E; Tosato F; Caprini D; Folli V; Friedman J; Bocchinfuso G; Martire A; Di Schiavi E; Leuzzi V; Martinelli S
Hum Mol Genet; 2022 Mar; 31(6):929-941. PubMed ID: 34622282
[TBL] [Abstract][Full Text] [Related]
12. Molecular annotation of G protein variants in a neurological disorder.
Knight KM; Obarow EG; Wei W; Mani S; Esteller MI; Cui M; Ma N; Martin SA; Brinson E; Hewitt N; Soden GM; Logothetis DE; Vaidehi N; Dohlman HG
Cell Rep; 2023 Dec; 42(12):113462. PubMed ID: 37980565
[TBL] [Abstract][Full Text] [Related]
13. GNAO1 Mutations Affecting the N-Terminal α-Helix of Gαo Lead to Parkinsonism.
Solis GP; Larasati YA; Thiel M; Koval A; Koy A; Katanaev VL
Mov Disord; 2024 Mar; 39(3):601-606. PubMed ID: 38358016
[TBL] [Abstract][Full Text] [Related]
14. Visual Function in Children with GNAO1-Related Encephalopathy.
Gambardella ML; Pede E; Orazi L; Leone S; Quintiliani M; Amorelli GM; Petrianni M; Galanti M; Amore F; Musto E; Perulli M; Contaldo I; Veredice C; Mercuri EM; Battaglia DI; Ricci D
Genes (Basel); 2023 Feb; 14(3):. PubMed ID: 36980817
[TBL] [Abstract][Full Text] [Related]
15. Mouse models characterize GNAO1 encephalopathy as a neurodevelopmental disorder leading to motor anomalies: from a severe G203R to a milder C215Y mutation.
Silachev D; Koval A; Savitsky M; Padmasola G; Quairiaux C; Thorel F; Katanaev VL
Acta Neuropathol Commun; 2022 Jan; 10(1):9. PubMed ID: 35090564
[TBL] [Abstract][Full Text] [Related]
16. Spectrum of movement disorders in GNAO1 encephalopathy: in-depth phenotyping and case-by-case analysis.
Kim SY; Shim Y; Ko YJ; Park S; Jang SS; Lim BC; Kim KJ; Chae JH
Orphanet J Rare Dis; 2020 Dec; 15(1):343. PubMed ID: 33298085
[TBL] [Abstract][Full Text] [Related]
17. An intronic GNAO1 variant leading to in-frame insertion cause movement disorder controlled by deep brain stimulation.
Miyamoto S; Nakashima M; Fukumura S; Kumada S; Saitsu H
Neurogenetics; 2022 Apr; 23(2):129-135. PubMed ID: 35147852
[TBL] [Abstract][Full Text] [Related]
18. [Effective Viral Delivery of Genetic Constructs to Neuronal Culture for Modeling and Gene Therapy of GNAO1 Encephalopathy].
Lunev EA; Shmidt AA; Vassilieva SG; Savchenko IM; Loginov VA; Marina VI; Egorova TV; Bardina MV
Mol Biol (Mosk); 2022; 56(4):604-618. PubMed ID: 35964317
[TBL] [Abstract][Full Text] [Related]
19. Clinical Cases and the Molecular Profiling of a Novel Childhood Encephalopathy-Causing
Larasati YA; Solis GP; Koval A; Griffiths ST; Berentsen R; Aukrust I; Lesca G; Chatron N; Ville D; Korff CM; Katanaev VL
Cells; 2023 Oct; 12(20):. PubMed ID: 37887313
[TBL] [Abstract][Full Text] [Related]
20. Neonatal epileptic encephalopathy caused by de novo GNAO1 mutation misdiagnosed as atypical Rett syndrome: Cautions in interpretation of genomic test results.
Gerald B; Ramsey K; Belnap N; Szelinger S; Siniard AL; Balak C; Russell M; Richholt R; De Both M; Claasen AM; Schrauwen I; Huentelman MJ; Craig DW; Rangasamy S; Narayanan V
Semin Pediatr Neurol; 2018 Jul; 26():28-32. PubMed ID: 29961512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
